<DOC>
	<DOCNO>NCT00214877</DOCNO>
	<brief_summary>While many bipolar patient treat mood stabilize medication experience improvement symptom , continue ongoing difficulty concentration memory . The purpose study look whether symptom improve add compound methylene blue treatment plan patient already take lamotrigine . Methylene blue available 'over counter medication ' Canada . It study long-term treatment mood symptom bipolar disorder . Several clinical study do bipolar disorder report methylene blue positive effect cognition mood . It important research area know , patient continue ongoing cognitive difficulty , recognize standard care bipolar patient experience type deficit .</brief_summary>
	<brief_title>Methylene Blue Cognitive Dysfunction Bipolar Disorder</brief_title>
	<detailed_description>This double blind cross-over study . There two dose range study . A cross design mean patient start one dose range others another . About half way study , patient switch dose range . Patients partially stabilize lamotrigine randomize either subtherapeutic ( 16mg ) therapeutic ( 200mg ) dose methylene blue . This design necessary methylene blue stain urine thus possible use traditional placebo . Double-blind mean neither doctor patient know strength study drug patient point study . The study conduct three centre , recruit 20 subject two-year period . The duration study 6 month .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Methylene Blue</mesh_term>
	<criteria>Men woman age 18 65 meet RDC DSMIV criterion bipolar I bipolar II disorder recruit . All subject interview use SADS interview ( 40 ) add question arrive DSMIV diagnose well . The patient treat lamotrigine main mood stabilizer . Patients recruit study show least partial response prophylactic treatment respect mood symptom . HAMD ( 17 item ) score study entry 15 low Y MRS score less 15 . Patients able give inform consent Patients active substance abuse dependence history within past two year Physical illness , mainly liver kidney disorder G6PD deficiency Subjects previously treat methylene blue Pregnant breastfeed woman Subjects ECT within past two year Patients know brain injury loss consciousness duration great ten minute Subjects take concurrent medication know cognitive effect ( eg . beta blocker )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>methylene blue cognitive dysfunction bipolar disorder</keyword>
</DOC>